Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) major shareholder Robert M. Williams, Jr. sold 750,000 shares of Aveanna Healthcare stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $5.20, for a total value of $3,900,000.00. Following the sale, the insider now directly owns 28,890,756 shares of the company's stock, valued at approximately $150,231,931.20. This trade represents a 2.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.
Aveanna Healthcare Stock Performance
NASDAQ:AVAH traded down $0.17 on Friday, reaching $4.91. The company's stock had a trading volume of 437,916 shares, compared to its average volume of 327,223. The firm has a market cap of $957.91 million, a PE ratio of -14.44 and a beta of 2.03. The business's 50-day moving average price is $5.09 and its two-hundred day moving average price is $4.91. Aveanna Healthcare Holdings Inc. has a 1-year low of $2.32 and a 1-year high of $6.19.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on the company. UBS Group boosted their target price on Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research note on Friday, May 9th. Truist Financial decreased their target price on Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a research note on Friday, April 11th.
Get Our Latest Report on Aveanna Healthcare
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of AVAH. First Eagle Investment Management LLC acquired a new position in shares of Aveanna Healthcare during the fourth quarter worth about $1,992,000. Nuveen LLC acquired a new position in shares of Aveanna Healthcare during the first quarter worth about $1,692,000. Millennium Management LLC boosted its position in shares of Aveanna Healthcare by 105.0% during the fourth quarter. Millennium Management LLC now owns 400,374 shares of the company's stock worth $1,830,000 after buying an additional 205,023 shares during the period. Jacobs Levy Equity Management Inc. boosted its position in shares of Aveanna Healthcare by 50.1% during the fourth quarter. Jacobs Levy Equity Management Inc. now owns 533,196 shares of the company's stock worth $2,437,000 after buying an additional 177,856 shares during the period. Finally, Mackenzie Financial Corp boosted its position in shares of Aveanna Healthcare by 145.9% during the first quarter. Mackenzie Financial Corp now owns 263,662 shares of the company's stock worth $1,429,000 after buying an additional 156,439 shares during the period. 87.96% of the stock is owned by institutional investors and hedge funds.
Aveanna Healthcare Company Profile
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Further Reading

Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.